Cryotherapy for Health & Longevity - Quick Reference Sheet

Cryotherapy for Health & Longevity

Created on 07/11/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Brief, deliberate exposure to extreme cold via cold-air chambers or ice-cold water. Best-supported for faster recovery and less muscle soreness after hard exercise, plus a short-term mood lift, easing of inflammatory joint pain, and lower inflammation signals. Effects on sleep, wellbeing, heart-rhythm balance, and blood sugar are smaller or mixed; metabolic and longevity claims remain unproven. (Full Review)

Protocol

Whole-Body Cryotherapy
2–3 min
−110 °C to −140 °C, 2–3×/week
Cold-Water Immersion
5–10 min
10–15 °C; ~11 min/week over 2–4 sessions
Best Time of Day
Morning
Alertness effect promotes wakefulness; activating near bedtime
Time to effect
Recovery
24–72 h
Reduced muscle soreness after exercise
Mood & Alertness
Single session
Acute lift persisting one to several hours
Inflammation & Wellbeing
A few weeks
Emerges over a few weeks of regular use

Benefits

Contraindications
  • Uncontrolled or severe hypertension (above ~160/100 mmHg)
  • Recent myocardial infarction (within ~6 months)
  • Unstable angina
  • Significant arrhythmia
  • Severe or unstable coronary or valvular disease
  • Raynaud's phenomenon
  • Cold urticaria or cryoglobulinemia
  • Peripheral neuropathy
  • Open wounds or active skin infection
  • Pregnancy
Key Interactions
  • Beta-blockers (metoprolol, atenolol)
  • Antihypertensives and vasodilators
  • Stimulant decongestants (pseudoephedrine, phenylephrine)
  • High-dose caffeine and stimulant pre-workouts (synephrine, yohimbine)
  • Alcohol, nitrates, high-dose beetroot/nitrate
  • Cold within ~6 h after resistance training

Risk & Side Effects

  • High: Cold burns and frostbite; acute blood-pressure and cardiovascular strain
  • Medium: Blunting of muscle hypertrophy and strength adaptation; cold-shock response and drowning risk
  • Low: Peripheral nerve injury; cold urticaria and allergic reactions; headache and transient dizziness; asphyxiation from nitrogen-cooled chambers
  • Speculative: Impaired long-term adaptive signaling; afterdrop hypothermia

Monitoring

Marker Target Why
Resting blood pressure ~110–125 / 70–80 mmHg Primary safety gate; cold acutely raises it
Resting heart rate ~50–65 bpm Tracks autonomic adaptation over time
Heart rate variability (HRV) Higher is generally better Reflects parasympathetic balance cold may improve
High-sensitivity C-reactive protein (hs-CRP) <1.0 mg/L Gauges the anti-inflammatory effect claimed for cold
Fasting glucose ~70–85 mg/dL Screens for metabolic response where claimed
Hemoglobin A1c (HbA1c) <5.4% Longer-term view of any glucose effect
Fasting lipid panel Triglycerides <90 mg/dL; HDL >50 mg/dL Context for any metabolic change

Cadence: Blood pressure and heart rate at baseline, ~4 weeks, then every 3–6 months; inflammatory and metabolic markers every 6–12 months

Qualitative Assessment

  • Sleep quality (ease of falling asleep, restfulness)
  • Mood and sense of calm or resilience after sessions
  • Energy and alertness in the hours following cold
  • Muscle soreness and perceived recovery between training sessions
  • Joint comfort and mobility (for those using cold for inflammatory pain)